BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 38555384)

  • 1. Quantitative profiling N1-methyladenosine (m1A) RNA methylation from Oxford nanopore direct RNA sequencing data.
    Chen S; Meng J; Zhang Y
    Methods; 2024 May; 228():30-37. PubMed ID: 38768930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of molecular subtypes and a prognostic signature based on m6A/m5C/m1A-related genes in lung adenocarcinoma.
    Zhang Y; Jia Q; Li F; Luo X; Wang Z; Wang X; Wang Y; Zhang Y; Li M; Bian L
    Sci Rep; 2024 Mar; 14(1):7543. PubMed ID: 38555384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of m6A/m5C/m1A regulated lncRNA signature for prognostic prediction, personalized immune intervention and drug selection in LUAD.
    Ma C; Gu Z; Yang Y
    J Cell Mol Med; 2024 Apr; 28(8):e18282. PubMed ID: 38647237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Construction of a prognostic model for lung adenocarcinoma based on m6A/m5C/m1A genes.
    Ding H; Teng Y; Gao P; Zhang Q; Wang M; Yu Y; Fan Y; Zhu L
    Hum Mol Genet; 2024 Mar; 33(7):563-582. PubMed ID: 38142284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploration and validation of a combined Hypoxia and m6A/m5C/m1A regulated gene signature for prognosis prediction of liver cancer.
    Ren M; Fan B; Cao G; Zong R; Feng L; Sun H
    BMC Genomics; 2023 Dec; 24(1):776. PubMed ID: 38097948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and validation of a novel prognostic signature based on m6A/m5C/m1A-related genes in hepatocellular carcinoma.
    Xiao Y; Li J; Wu J
    BMC Med Genomics; 2023 Jul; 16(1):177. PubMed ID: 37525171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic Value and Genome Signature of m6A/m5C Regulated Genes in Early-Stage Lung Adenocarcinoma.
    Tian L; Wang Y; Tian J; Song W; Li L; Che G
    Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Robust analysis of a novel PANoptosis-related prognostic gene signature model for hepatocellular carcinoma immune infiltration and therapeutic response.
    Wei Y; Lan C; Yang C; Liao X; Zhou X; Huang X; Xie H; Zhu G; Peng T
    Sci Rep; 2023 Sep; 13(1):14519. PubMed ID: 37666920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aberrant m5C hypermethylation mediates intrinsic resistance to gefitinib through NSUN2/YBX1/QSOX1 axis in EGFR-mutant non-small-cell lung cancer.
    Wang Y; Wei J; Feng L; Li O; Huang L; Zhou S; Xu Y; An K; Zhang Y; Chen R; He L; Wang Q; Wang H; Du Y; Liu R; Huang C; Zhang X; Yang YG; Kan Q; Tian X
    Mol Cancer; 2023 May; 22(1):81. PubMed ID: 37161388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel oxidative-stress related lncRNA signature predicts the prognosis of clear cell renal cell carcinoma.
    Zhang Y; Zhou G; Shi W; Shi W; Hu M; Kong D; Long R; Chen N
    Sci Rep; 2023 Apr; 13(1):5740. PubMed ID: 37029263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N
    Li J; Zhang H; Wang H
    Comput Struct Biotechnol J; 2022; 20():6578-6585. PubMed ID: 36467585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel cell senescence-related IncRNA survival model associated with the tumor immune environment in colorectal cancer.
    Xu C; Li F; Liu Z; Yan C; Xiao J
    Front Immunol; 2022; 13():1019764. PubMed ID: 36275644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploring anti-androgen therapies in hormone dependent prostate cancer and new therapeutic routes for castration resistant prostate cancer.
    Harris AE; Metzler VM; Lothion-Roy J; Varun D; Woodcock CL; Haigh DB; Endeley C; Haque M; Toss MS; Alsaleem M; Persson JL; Gudas LJ; Rakha E; Robinson BD; Khani F; Martin LM; Moyer JE; Brownlie J; Madhusudan S; Allegrucci C; James VH; Rutland CS; Fray RG; Ntekim A; de Brot S; Mongan NP; Jeyapalan JN
    Front Endocrinol (Lausanne); 2022; 13():1006101. PubMed ID: 36263323
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.